| Disparities in Chronic Kidney Disease Prevalence among Males and Females in 195 Countries: Analysis of the Global Burden of Disease 2016 Study |
22 |
| Consequences of Glomerular Hyperfiltration: The Role of Physical Forces in the Pathogenesis of Chronic Kidney Disease in Diabetes and Obesity |
20 |
| Incidence, Prevalence, and Duration of Chronic Kidney Disease in Taiwan: Results from a Community-Based Screening Program of 094 Individuals |
17 |
| Delayed Graft Function: The AKI of Kidney Transplantation |
16 |
| Rationale and Design of a Randomized Placebo-Controlled Clinical Trial Assessing the Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease |
11 |
| Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial |
11 |
| Inflammation in Diabetic Kidney Disease |
11 |
| Underlying Mechanisms of Renal Lipotoxicity in Obesity |
11 |
| Acute Kidney Injury and Fluid Resuscitation in Septic Patients: Are We Protecting the Kidney? |
10 |
| Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease |
9 |
| Longitudinal Experience with Remote Monitoring for Automated Peritoneal Dialysis Patients |
9 |
| Amelioration of Uremic Toxin Indoxyl Sulfate-Induced Osteoblastic Calcification by SET Domain Containing Lysine Methyltransferase 7/9 Protein |
9 |
| Leptospirosis Renal Disease: Emerging Culprit of Chronic Kidney Disease Unknown Etiology |
9 |
| Iron Homeostasis Pathways as Therapeutic Targets in Acute Kidney Injury |
8 |
| UK Renal Registry 20th Annual Report: Chapter 2 UK Renal Replacement Therapy Adult Prevalence in 2016: National and Centre-specific Analyses |
8 |
| UK Renal Registry 20th Annual Report: Chapter 1 UK Renal Replacement Therapy Adult Incidence in 2016: National and Centre-specific Analyses |
8 |
| UK Renal Registry 20th Annual Report: Chapter 5 Survival and Cause of Death in UK Adult Patients on Renal Replacement Therapy in 2016: National and Centre-specific Analyses |
8 |
| Renoprotective Effects of Metformin |
8 |
| Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis |
8 |
| An Introduction to Contrast-Enhanced Ultrasound for Nephrologists |
7 |
| Checkpoint Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 is Upregulated and Independently Predicts Unfavorable Prognosis in Bladder Urothelial Carcinoma |
7 |
| Molecular Basis of Cystinosis: Geographic Distribution, Functional Consequences of Mutations in the CTNS Gene, and Potential for Repair |
7 |
| The Role of Uric Acid in Acute Kidney Injury |
7 |
| Perioperative Acute Kidney Injury: Prevention, Early Recognition, and Supportive Measures |
7 |
| Cell Death Pathways Drive Necroinflammation during Acute Kidney Injury |
7 |
| Spontaneous Extracellular Matrix Accumulation in a Human in vitro Model of Renal Fibrosis Is Mediated by alpha V Integrins |
7 |
| Association of Ultrafiltration Rate with Mortality in Incident Hemodialysis Patients |
7 |
| Low Cerebral Oxygenation Is Associated with Cognitive Impairment in Chronic Hemodialysis Patients |
6 |
| Acute Kidney Injury in Real Time: Prediction, Alerts, and Clinical Decision Support |
6 |
| Circulating miR-421 Targeting Leucocytic Angiotensin Converting Enzyme 2 Is Elevated in Patients with Chronic Kidney Disease |
6 |
| Fabry Disease Prevalence in Renal Replacement Therapy in Turkey |
6 |
| Utility of Cardiac Biomarkers in the Setting of Kidney Disease |
6 |
| Furosemide Stress Test as a Predicting Biomarker for Delayed Graft Function in Kidney Transplantation |
6 |
| Diagnostic Accuracy of Frailty Screening Methods in Advanced Chronic Kidney Disease |
6 |
| Safety of Iohexol Administration to Measure Glomerular Filtration Rate in Different Patient Populations: A 25-Year Experience |
5 |
| A de novo KCNA1 Mutation in a Patient with Tetany and Hypomagnesemia |
5 |
| Inhibition of miR-155 Ameliorates Acute Kidney Injury by Apoptosis Involving the Regulation on TCF4/Wnt/beta-Catenin Pathway |
5 |
| Risk Prediction Models for Acute Kidney Injury in Critically Ill Patients: Opus in Progressu |
5 |
| Predicting Risk of Recurrent Acute Kidney Injury: A Systematic Review |
5 |
| The Future: Experimental Therapies for Renal Disease in Diabetes |
5 |
| Sepsis-Associated Acute Kidney Injury: A Problem Deserving of New Solutions |
4 |
| Acute Kidney Injury following Cardiac Surgery: A Clinical Model |
4 |
| MicroRNAs in Acute Kidney Injury |
4 |
| Importance of Genetic Diagnostics in Adult-Onset Focal Segmental Glomerulosclerosis |
4 |
| Association of Thyrotropin Concentration with Chronic Kidney Disease in a Japanese General Population Cohort |
4 |
| Safety of Outpatient Kidney Biopsies |
4 |
| Renal PGC1 alpha May Be Associated with Recovery after Delayed Graft Function |
4 |
| Glomerular Hyperfiltration: An Early Marker of Nephropathy in Fabry Disease |
4 |
| Early and Severe Polycystic Kidney Disease and Related Ciliopathies: An Emerging Field of Interest |
4 |
| Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease |
4 |
